Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaojin pills plus levothyroxine in breast cancer patients with thyroid nodule
ChiCTR-IPR-16009046Phase 4Recruiting
- Sponsor
- Department of Endocrine and Breast Surgery, First Affiliated Hospital of Chongqing Medical University
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Xiaojin and levothyroxine sodium in thyroid nodule (3 arms), sponsored by Department of Endocrine and Breast Surgery, First Affiliated Hospital of Chongqing Medical University. Primary endpoints: Cure rate, Excellent rate and 3 more. Started Aug 2016; status: recruiting.
02
Drugs
Xiaojinlevothyroxine sodium
03
Conditions
thyroid nodule
Beyond the preview
Go deeper on ChiCTR-IPR-16009046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009046.